Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.45 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28932569 | 1.00 | KMT2A (0.55) | KMT2AMAPTHTR2CDGKACES2 | |
| SCHEMBL28017366 | 0.98 | KMT2A (0.53) | KMT2AMAPTHTR2CDGKACES2 | |
| SCHEMBL27403983 | 0.94 | MAPT (0.57) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL28921483 | 0.94 | MAPT (0.57) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL29172607 | 0.90 | MAPT (0.53) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL394559 | 0.87 | DGKA (0.61) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL905880 | 0.87 | DGKA (0.61) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL225274 | 0.87 | DGKA (0.61) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL337904 | 0.87 | DGKA (0.61) | KMT2AMAPTDGKACES2CES1 | |
| SCHEMBL8683587 | 0.87 | DGKA (0.61) | KMT2AMAPTDGKACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170267766-A1 | IGF-1R ANTIBODY AND ITS USE AS ADDRESSING VEHICLE FOR THE TREATMENT OF CANCER | PIERRE FABRE MEDICAMENT (FR) | 2017-09-21 | — | — | US | disclosed |
| US-9624308-B2 | Antigen binding proteins | PIERRE FABRE MEDICAMENT (FR) | 2017-04-18 | — | — | US | disclosed |
| EP-3134438-A1 | IGF-1R ANTIBODY AND ITS USE AS ADDRESSING VEHICLE FOR THE TREATMENT OF CANCER | Pierre Fabre Médicament (FR) | 2017-03-01 | — | — | EP | disclosed |
| US-20160046725-A1 | NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER | PIERRE FABRE MEDICAMENT (FR) | 2016-02-18 | — | — | US | disclosed |
| WO-2015162292-A1 | IGF-1R ANTIBODY AND ITS USE AS ADDRESSING VEHICLE FOR THE TREATMENT OF CANCER | PIERRE FABRE MEDICAMENT (FR) | 2015-10-29 | — | — | WO | disclosed |
| EP-2914630-A1 | NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER | Pierre Fabre Médicament (FR) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014068139-A1 | NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER | PIERRE FABRE MEDICAMENT (FR) | 2014-05-08 | — | — | WO | disclosed |
| WO-2011089216-A1 | DIPEPTIDE-BASED PRODRUG LINKERS FOR ALIPHATIC AMINE-CONTAINING DRUGS | ASCENDIS PHARMA AS (DK) | 2011-07-28 | — | — | WO | disclosed |